XNAS
OPXS
Market cap86mUSD
Jul 09, Last price
13.36USD
1D
4.29%
1Q
14.19%
Jan 2017
1,884.85%
IPO
4,758.18%
Name
Optex Systems Holdings Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Optex Systems Holdings, Inc. specializes in the production and supply of advanced optical sighting equipment and related assemblies. The company's primary clients include the U.S. Department of Defense, international military organizations, and commercial entities within the United States. Its comprehensive product lineup features various periscope models, including robust laser-protected and standard plastic/glass versions, M17 day/thermal periscopes, and vision blocks. Optex also develops sophisticated sighting solutions such as digital day and night systems, M36 thermal periscopes, backup sights, unity mirrors, and specialized commander weapon station sights, alongside providing maintenance for optical weapon systems. Furthermore, the company manufactures critical components for howitzers, such as the M137 telescope, M187 mount, M119 aiming device, and aiming circles. Its Applied Optics Center produces an array of precision optical items, including laser filter units, optical assemblies, day windows, binoculars, and custom thin-film coatings. Additional offerings encompass muzzle reference systems, collimators, various optical lenses, elements, and windows, as well as diverse periscope configurations, rifle and surveillance sights, and night vision optical assemblies. These specialized products are integrated into a wide range of U.S. military ground vehicles, notably the Abrams, Bradley, and Stryker fighting vehicle families, along with light armored and armored security vehicles. Optex directly markets its products to the U.S. federal government, prime contractors, and foreign governments. Established in 1987 and based in Richardson, Texas, Optex Systems Holdings, Inc. operates as a subsidiary of Sileas Corporation.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||